Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer

Xian Lin, Hong Ru Li, Xiao Fen Lin, Mei E. Yu, Xun Wei Tu, Zhi Dan Hua, Ming Lin, Neng Luan Xu, Li Li Han, Yu Sheng Chen

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Livin, an inhibitor of apoptosis protein (IAP), is overexpressed in various cancers and decreases tumor sensitivity to chemotherapy and radiotherapy. However, the effect of Livin on lung adenocarcinoma metastasis and the specific mechanism involved remain unclear. RNAi technology was used to stably silence Livin in A549 cells in the present study. The effect of Livin on tumor growth and invasion was investigated in lung cancer cells in vitro and animal models were established to determine the anti-metastasis ability of Livin silencing in vivo. The results indicated that Livin knock-down suppressed cell proliferation and inhibited cell invasion, accompanied by downregulation of VEGF and MMP-2/-9. Silencing of Livin resulted in the prevention of xenograft tumor formation. Seventy-five immunodeficient male BALB/C nude mice were randomly divided into three groups, the relative ratio of the areas with pulmonary nodules in the experimental group decreased from 46.71±7.27% to 11.07±2.94% compared with the negative control group (P<0.001), indicating the interaction between Livin, VEGF and MMPs. The xenograft tumor model of intravenous injection of tumor cells were successfully established and applied for the analysis of lung cancer tumorigenesis and metastasis in a time-dependent manner for the first time. Based on the reliable and reproducible animal model, our findings indicate that knock-down of Livin inhibits cell growth and invasion through blockade of the VEGF and MMPs pathways in lung cancer cells in vitro, and inhibits tumorigenesis and metastasis of lung cancer in vivo, suggesting that Livin is a promising antitumor target.

Original languageEnglish
Pages (from-to)657-667
Number of pages11
JournalInternational Journal of Oncology
Issue number2
StatePublished - 1 Aug 2015
Externally publishedYes


  • Intravenous injection
  • Livin
  • Lung adenocarcinoma
  • Metastasis
  • Xenograft tumor model


Dive into the research topics of 'Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer'. Together they form a unique fingerprint.

Cite this